{
    "status": "ok",
    "totalResults": 10,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "AtriCure Releases 2023 ESG Report",
            "description": "(marketscreener.com) \nAtriCure, Inc. , a leading innovator in surgical treatments and therapies for atrial fibrillation , left atrial appendage management and post-operative pain management, today announced that the company has published its 2023 Environmenta\u2026",
            "url": "https://www.marketscreener.com/quote/stock/ATRICURE-INC-8482/news/AtriCure-Releases-2023-ESG-Report-45347927/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-11-14T13:06:02Z",
            "content": "AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, toda\u2026 [+4081 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Short Interest in AtriCure, Inc. (NASDAQ:ATRC) Grows By 18.2%",
            "description": "AtriCure, Inc. (NASDAQ:ATRC \u2013 Get Free Report) was the target of a large growth in short interest in November. As of November 15th, there was short interest totalling 1,620,000 shares, a growth of 18.2% from the October 31st total of 1,370,000 shares. Based o\u2026",
            "url": "https://www.etfdailynews.com/2023/12/03/short-interest-in-atricure-inc-nasdaqatrc-grows-by-18-2/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/atricure-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-03T19:20:41Z",
            "content": "AtriCure, Inc. (NASDAQ:ATRC \u2013 Get Free Report) was the target of a large growth in short interest in November. As of November 15th, there was short interest totalling 1,620,000 shares, a growth of 18\u2026 [+4881 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "AtriCure (NASDAQ:ATRC) Stock Price Down 6%",
            "description": "Shares of AtriCure, Inc. (NASDAQ:ATRC \u2013 Get Free Report) fell 6% on Thursday . The stock traded as low as $33.12 and last traded at $33.36. 424,344 shares changed hands during trading, an increase of 25% from the average session volume of 340,155 shares. The \u2026",
            "url": "https://www.etfdailynews.com/2023/12/02/atricure-nasdaqatrc-stock-price-down-6/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/atricure-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-12-02T11:59:49Z",
            "content": "Shares of AtriCure, Inc. (NASDAQ:ATRC \u2013 Get Free Report) fell 6% on Thursday . The stock traded as low as $33.12 and last traded at $33.36. 424,344 shares changed hands during trading, an increase of\u2026 [+4985 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "B. Metzler seel. Sohn & Co. AG Has $2.59 Million Stake in AtriCure, Inc. (NASDAQ:ATRC)",
            "description": "B. Metzler seel. Sohn & Co. AG raised its position in shares of AtriCure, Inc. (NASDAQ:ATRC \u2013 Free Report) by 113.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional inve\u2026",
            "url": "https://www.etfdailynews.com/2023/11/27/b-metzler-seel-sohn-co-ag-has-2-59-million-stake-in-atricure-inc-nasdaqatrc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/atricure-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-27T16:02:42Z",
            "content": "B. Metzler seel. Sohn &amp; Co. AG raised its position in shares of AtriCure, Inc. (NASDAQ:ATRC \u2013 Free Report) by 113.7% in the 2nd quarter, according to the company in its most recent disclosure wit\u2026 [+5842 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Research Analysts\u2019 Weekly Ratings Changes for AtriCure (ATRC)",
            "description": "Several brokerages have updated their recommendations and price targets on shares of AtriCure (NASDAQ: ATRC) in the last few weeks: 11/9/2023 \u2013 AtriCure was upgraded by analysts at StockNews.com from a \u201csell\u201d rating to a \u201chold\u201d rating. 11/2/2023 \u2013 AtriCure ha\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/research-analysts-weekly-ratings-changes-for-atricure-atrc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/atricure-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T15:16:53Z",
            "content": "Several brokerages have updated their recommendations and price targets on shares of AtriCure (NASDAQ: ATRC) in the last few weeks:\r\n<ul><li>11/9/2023 \u2013 AtriCure was upgraded by analysts at StockNews\u2026 [+5148 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "AtriCure (NASDAQ:ATRC) Shares Gap Up to $35.07",
            "description": "Shares of AtriCure, Inc. (NASDAQ:ATRC \u2013 Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $35.07, but opened at $35.88. AtriCure shares last traded at $36.72, with a volume of 15,406 shares. Wall Street Analyst\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/atricure-nasdaqatrc-shares-gap-up-to-35-07/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/atricure-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T16:46:52Z",
            "content": "Shares of AtriCure, Inc. (NASDAQ:ATRC \u2013 Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $35.07, but opened at $35.88. AtriCure shares last traded at\u2026 [+5235 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "AtriCure (NASDAQ:ATRC) Sees Strong Trading Volume",
            "description": "Shares of AtriCure, Inc. (NASDAQ:ATRC \u2013 Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 874,822 shares traded hands during mid-day trading, an increase of 167% from the previous session\u2019s volume of 327,747 shares.The stock last\u2026",
            "url": "https://www.etfdailynews.com/2023/11/28/atricure-nasdaqatrc-sees-strong-trading-volume/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/atricure-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-28T22:58:54Z",
            "content": "Shares of AtriCure, Inc. (NASDAQ:ATRC \u2013 Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 874,822 shares traded hands during mid-day trading, an increase of 167% from th\u2026 [+5371 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "AtriCure (NASDAQ:ATRC) Lowered to \u201cSell\u201d at StockNews.com",
            "description": "StockNews.com downgraded shares of AtriCure (NASDAQ:ATRC \u2013 Free Report) from a hold rating to a sell rating in a report released on Wednesday. Other analysts also recently issued research reports about the stock. BTIG Research raised their price objective on \u2026",
            "url": "https://www.etfdailynews.com/2023/11/05/atricure-nasdaqatrc-lowered-to-sell-at-stocknews-com-2/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/atricure-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-05T05:44:41Z",
            "content": "StockNews.com downgraded shares of AtriCure (NASDAQ:ATRC \u2013 Free Report) from a hold rating to a sell rating in a report released on Wednesday.\r\nOther analysts also recently issued research reports ab\u2026 [+4959 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by StockNews.com",
            "description": "StockNews.com upgraded shares of AtriCure (NASDAQ:ATRC \u2013 Free Report) from a sell rating to a hold rating in a report published on Thursday. ATRC has been the topic of a number of other reports. JPMorgan Chase & Co. lowered their price target on shares of Atr\u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/atricure-nasdaqatrc-stock-rating-upgraded-by-stocknews-com/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/atricure-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T07:22:46Z",
            "content": "StockNews.com upgraded shares of AtriCure (NASDAQ:ATRC \u2013 Free Report) from a sell rating to a hold rating in a report published on Thursday.\r\nATRC has been the topic of a number of other reports. JPM\u2026 [+4603 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "AtriCure (NASDAQ:ATRC) Rating Reiterated by JMP Securities",
            "description": "AtriCure (NASDAQ:ATRC \u2013 Get Free Report)\u2018s stock had its \u201cmarket outperform\u201d rating reaffirmed by JMP Securities in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $60.00 target price on the medical devi\u2026",
            "url": "https://www.etfdailynews.com/2023/11/29/atricure-nasdaqatrc-rating-reiterated-by-jmp-securities/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/atricure-logo.jpg&w=240&h=240&zc=2",
            "publishedAt": "2023-11-29T16:43:11Z",
            "content": "AtriCure (NASDAQ:ATRC \u2013 Get Free Report)\u2018s stock had its \u201cmarket outperform\u201d rating reaffirmed by JMP Securities in a research report issued to clients and investors on Wednesday, Benzinga reports. T\u2026 [+5186 chars]"
        }
    ]
}